Clear 489 Results Filter Filter Results Type: Press Release Large Multi-Center Multi-Society Study of Impella-supported Patients Finds 30-day AMI Cardiogenic Shock Survival of 81% Type: Press Release Multi-Center Multi-Society Study of Impella®-Supported Patients with Cardiogenic Shock due to Myocarditis in Japan Achieves 30-day Survival of 77% Type: Press Release Yale University Study Demonstrates Significant Survival Benefit in High-Risk PCI with Impella Support Type: Press Release US FDA Grants 510(k) Clearance for Impella Low Profile Sheath Type: Press Release Abiomed Successfully Completes All Impella Post-Approval Studies for High-Risk PCI Cardiogenic Shock Post-Cardiotomy Cardiogenic Shock and Right Heart Failure Type: Press Release Abiomed Creates Patient Assistance Program to Address Disparities in Healthcare Type: Press Release Impella RP Flex with SmartAssist Receives FDA Approval to Treat Right Heart Failure Type: Press Release Johnson & Johnson to Acquire Abiomed Type: Press Release Abiomed Announces Second Quarter Revenue of $266 Million up 11% in Constant Currency* up 7% on a Reported Basis Year Over Year Type: Patient Stories Young Japanese Mom Enjoying Life After Surviving Heart Failure … 27 28 29 30 …
